# OnCo record nct00936390 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00936390/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00936390", "NCT00936390" ;
  schema:name "Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer"@en ;
  schema:description "A phase 3 trial of Bicalutamide, Flutamide, Goserelin / leuprolide, Buserelin, Triptorelin and Degarelix in Prostate cancer, run by Radiation Therapy Oncology Group, completed."@en ;
  schema:url <https://onco.cc/trials/nct00936390/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00936390> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:drugs <https://onco.cc/drugs/bicalutamide/>, <https://onco.cc/drugs/flutamide/>, <https://onco.cc/drugs/goserelin/>, <https://onco.cc/drugs/buserelin/>, <https://onco.cc/drugs/triptorelin/>, <https://onco.cc/drugs/degarelix/> .